The reporting process for the 12th batch of state-organized drug centralized procurement by pharmaceutical institutions will end on the afternoon of July 16. As of 12:00 noon on the 16th, a total of 45,000 pharmaceutical institutions had reported procurement requirements, involving more than 530 pharmaceutical companies with 65 procurement categories. On average, 15 companies of each category received demand, the number of enterprises with 5 varieties exceeded 30, and the largest number of enterprises reached 54. Pharmaceutical institutions that have not yet completed reporting are requested to complete the reporting process in a timely manner. We hope that pharmaceutical companies will prepare for bidding and quotations, carefully calculate according to their own costs and benefits and market competition pattern, make rational quotations and operate in good faith, and jointly create a healthy industry ecology and promote high-quality development of the industry.

The reporting process for the 12th batch of state-organized drug centralized procurement by pharmaceutical institutions will end on the afternoon of July 16. As of 12:00 noon on the 16th, a total of 45,000 pharmaceutical institutions had reported procurement requirements, involving more than 530 pharmaceutical companies with 65 procurement categories. On average, 15 companies of each category received demand, the number of enterprises with 5 varieties exceeded 30, and the largest number of enterprises reached 54. Pharmaceutical institutions that have not yet completed reporting are requested to complete the reporting process in a timely manner. We hope that pharmaceutical companies will prepare for bidding and quotations, carefully calculate according to their own costs and benefits and market competition pattern, make rational quotations and operate in good faith, and jointly create a healthy industry ecology and promote high-quality development of the industry.